Try GOLD - Free
Bayer’s Stroke-Prevention Drug Shows Positive Results at Trial
The Wall Street Journal
|November 25, 2025
Shares in Bayer rose after the company reported positive results from a clinical trial for an experimental stroke-preventing drug that had previously been shown to be ineffective in another trial.
Bayer's pharmaceutical business has been hit by pressure from drugs going off patent.
This story is from the November 25, 2025 edition of The Wall Street Journal.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
Listen
Translate
-
+
Change font size

